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of blood and blood products, such as the transmission
of viral infections, the induction of immunologic
transfusion reactions, and suppression of the immune
system.2
Recently, there has been a revival of interest on the
use of beating-heart operations for coronary artery
bypass grafting (CABG), with the suggestion that this
may reduce postoperative blood loss, the need for blood
transfusion, and costs.7-11 However, this has not been
confirmed with a prospective randomized study.
Furthermore, there are no data on the influence of beat-
ing-heart coronary grafting on postoperative hemato-
logic and hemostatic parameters.
The present prospective randomized study compared
postoperative blood loss identified as total chest tube
I n recent years life-threatening morbidity and mortali-ty after cardiopulmonary bypass (CPB) has been sig-
nificantly decreased.1-3 However, the duration of CPB
and its influence on hemostasis, platelet count, and
function still contributes to postoperative bleeding.1-5
Despite improvements in donor screening methods,6
there is still an important risk related to the transfusion
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monary bypass and cardioplegic arrest and (2) off-pump treatment on the
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drainage and transfusion requirement in patients under-
going CABG either on the beating heart or with CPB
and cardioplegic arrest.
Methods
From March 1997 to August 1998, 538 patients underwent
first-time CABG under the supervision of a single consultant
(G.D.A.). Eligibility for operation was based on the medical his-
tory and the most recent angiogram. The investigations report-
ed in the present study are part of a more comprehensive analy-
sis between the 2 groups, which included the evaluation of
economic outcome, length of stay, and postoperative morbidity.
Patient selection and randomization. Eligibility to enter
the trial was based on the following exclusion criteria: preex-
isting coagulopathy or other disorders of hemostasis, such as
low platelet count, known platelet dysfunction, or history of
bleeding tendencies; left ventricular ejection fraction of less
than 30%; recent myocardial infarction (<1 month); reopera-
tion; previous stroke or transient ischemic attack; and respira-
tory or renal impairment. Patients with coronary artery disease
involving branches of the circumflex artery distal to the first
obtuse marginal branch and posterior branches originating
from the left system were also excluded from the study because
these were believed to be technically difficult for adequate
revascularization at the beginning of our experience with off-
pump operations. A total of 200 patients who met the eligibili-
ty criteria and consented to participate in the trial were indi-
vidually randomized to undergo myocardial revascularization
with either (1) a conventional on-pump operation or (2) an off-
pump operation on the beating heart. The randomization codes
were concealed in numbered, sealed, opaque envelopes. The
treatment allocation for a patient was determined by opening
the next envelope the evening before the operation.
The study was approved by the United Bristol Healthcare
Trust Ethics Committee.
Anesthetic and heparin management. Anesthetic tech-
nique was standardized for all patients, as previously report-
ed.11 In brief, this consisted of intravenous anesthesia with
propofol and remifentanil infusions. Neuromuscular block-
ade was achieved with pancuronium or vecuronium bromide,
and the lungs were ventilated to normocapnia.
In the on-pump group heparin was given at a dose of 300
IU/kg to achieve a target activated clotting time (ACT) of 480
seconds or above before commencement of CPB. In the off-
pump group, heparin (100 IU/kg) was administered before
the start of the first anastomosis to achieve an ACT of 250 to
350 seconds.11
Surgical technique
On-pump group. CPB was instituted by means of ascend-
ing aortic cannulation and 2-stage venous cannulation of the
right atrium, as previously described.11 Nonpulsatile flow
was used, and flow rates throughout bypass were 2.4 L · m–2
· min–1. Systemic temperature was kept between 34°C and
36°C. Myocardial protection was achieved by using intermit-
tent antegrade hyperkalemic warm blood cardioplegia.12
Off-pump group. The method of exposure and stabilization
used to perform the anastomosis consisted of the technique pre-
viously described by our group.8,13 The target vessel was
exposed and snared above the anastomotic site by using a 4-0
Prolene suture (Ethicon, Inc, Somerville, NJ) with a soft plastic
snugger to prevent coronary injury. An intracoronary shunt
(Anastoflo Intravascular Shunt, Research Medical, Inc, Salt
Lake City, Utah) was used only in case of relative electrocar-
diographic or hemodynamic instability or with excessive bleed-
ing during the construction of the distal anastomoses.
Fluid management. In the on-pump group the extracorpo-
real circuit was primed with 1000 mL of Hartmann solution,
500 mL of colloidal plasma volume substitute (Gelofusine;
Braun-Milsungen), 0.5 g/kg mannitol, and 6000 IU of
heparin. During CPB, when additional volume was required,
this consisted of Gelofusine plasma volume substitute (he-
matocrit level, >22%) or red blood cells (hematocrit level <
22%). In the off-pump group, intraoperative fluid administra-
tion (Gelofusine) was used together with increments of
metaraminol (0.5-1 mg) to maintain the mean systemic pres-
sure at 60 mm Hg or greater.
Fluid management postoperatively consisted in both
groups of 5% dextrose infused at 1 mL · kg–1 · h–1, with addi-
tional Gelofusine or blood to maintain normovolemia and the
hematocrit level at greater than 24%.
Management of postoperative bleeding and related
treatment. A minimum of 2 chest drains were placed in the
mediastinum and pleura if the internal thoracic artery was
harvested. After closure of the chest, continuous suction (5-
10 mm Hg) was applied to the drains, which were milked at
30-minute intervals to ensure tube patency. Postoperative
blood loss measured as total chest tube drainage was record-
ed, starting immediately after closure of the chest in the oper-
ating theater until the chest drains were removed, providing
the drainage was less than 20 mL/h for 3 consecutive hours.
On arrival in the intensive care unit (ICU), all patients
underwent a routine screening, which included ACT, coagu-
lation profile, and full blood count. Derangements of the
coagulation profile were treated by an independent intensivist
only in cases of excessive bleeding (>150 mL/h over 2 con-
secutive hours), with a specific diagnosis-directed therapy.
Elevation of ACT of more than 30 seconds when compared
with baseline values was treated with an additional dose of
protamine (ie, 25 mg). Values of prothrombin time (PT), acti-
vated partial thromboplastin time (APTT), and international
normalized ratio (INR) of more than 1.5 times control values
suggested factor deficiency and were corrected by infusion of
fresh frozen plasma. A platelet count of less than 80,000/µL
was an indication for platelet transfusion. A hematocrit level
of less than 24% was corrected by transfusion of red blood
cells. Indications for reopening were a blood loss of greater
than 500 mL over the first hour, greater than 300 mL for 2
consecutive hours, greater than 200 mL for 3 consecutive
hours, or greater than 1 L over the first 8 hours.
Clotting profiles and hematologic indices. We also
sought to retrospectively review the blood clotting profiles
and hematologic indices. Data were obtained as part of the
routine clinical monitoring of patients undergoing coronary
operations at our institution. These included PT, APTT, acti-
vated partial thromboplastin ratio (APTR), INR, platelet
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count, hematocrit level, and hemoglobin level. The time of
sampling was prospectively defined at baseline and at 1, 12,
36, and 60 hours postoperatively. To prevent the potential bias
by discarding whole patients, those with a missing sample or
with a sample drawn out of the predefined time of observa-
tion were not excluded from the retrospective analysis.
Laboratory methods. Blood samples were collected from
the central venous line at the following times: before induc-
tion of anesthesia (T0); on arrival in the ICU (T1); and there-
after at 12, 36, and 60 hours (T2-T4). The blood samples for
evaluation of hematologic indices (hemoglobin levels, he-
matocrit levels, and platelet counts) were drawn into 4-mL
vacuum containers containing potassium ethylene diamine-
tetraacetic acid. Analysis was then carried out on an H2/H3
Technicon instrument (Bayer A/G, Leverkusen, Germany). A
further 4 mL of blood was drawn into a vacuum container
with sodium citrate and was then used to assess the clotting
profile (APTT, APTR, PT, and INR) with an ACL analyzer
(Instrumentation Laboratories, Inc, Lexington, Mass).
Transfusion costs. The total (intraoperative and postoper-
ative) number of units of red blood cells, fresh frozen plasma,
and platelets were recorded for each patient, and cost was cal-
culated from the number of units transfused only.
Sample size. Postoperative stay in our institution for con-
ventional CABG in 1997 was 7.31 ± 1.6 days. We considered
a clinically meaningful reduction in this period to be 1 day, a
reduction of 14%. To detect a clinically meaningful reduction
with a probability of 0.9 and choosing a 5% significance
level, it was calculated that 100 patients per group would be
required.
Statistical analysis. All collected data were first investi-
gated by using simple tabulations and histograms to establish
the distribution of the data. We acknowledge that the sample
size depended on the length of postoperative stay being treat-
ed as a continuous variable. Investigation of the data revealed
that most of the postoperative length of stay values lay in a
narrow range and were highly positively skewed. Because
these were not found to be continuous and not normally dis-
tributed, postoperative length of stay was treated as ordered
discrete data, as was intubation time and ICU stay. The data
were arranged as contingency tables (cross-tabulations), with
the criteria that each cell of the table has an expected fre-
quency of 5 or more (Table I). To test for differences between
the on- and off-pump groups, χ2-based tests were used. Data
were presented as numbers of patients and cumulative per-
centages. Because the cells of the table had a natural ordering
(eg, 4 days to ≥10 days), χ2 values for trend were first calcu-
lated. These were then subtracted from the overall χ2 value to
obtain the variation attributable to differences between the 2
groups.14
The numbers of transfused units received by each patient
were arranged as contingency tables, again with the condition
that each cell of the table had an expected frequency of 5 or
more. The resulting 2 × 2 tables were analyzed with χ2 tests.
Other preoperative and postoperative variables having binary
outcomes were analyzed in a similar fashion.
Chest tube drainage data were found to be positively
skewed. To calculate 95% confidence intervals (CIs) for these
data, it was found that a log10 approximation to the normal
distribution was appropriate.
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Table I. Coagulation indices
On-pump predicted means (median) Off-pump predicted means (median)
Log10 (PT)
T0 preoperative (1.1303) (1.12)
T1 1 h postoperatively 1.2645 (1.26245) 1.23082 (1.23300)
T2 12 h postoperatively 1.23065 (1.22011) 1.19601 (1.20683)
T3 36 h postoperatively 1.19584 (1.19312) 1.1612 (1.17026)
T4 60 h postoperatively 1.17965 (1.15685) 1.14501 (1.11394)
Log10 (APTT)
T0 preoperative (1.49554) (1.487138)
T1 1 h postoperatively 1.56678 (1.56703) 1.54300 (1.55267)
T2 12 h postoperatively 1.53561 (1.52634) 1.51183 (1.51720)
T3 36 h postoperatively 1.50444 (1.50379) 1.48065 (1.51983)
T4 60 h postoperatively 1.48994 (1.48996) 1.46616 (1.45788)
Log
e
(INR)
T0 preoperative (0) (0)
T1 1 h postoperatively 0.38714 (0.33647) 0.30943 (0.33647)
T2 12 h postoperatively 0.29568 (0.26236) 0.21797 (0.26236)
T3 36 h postoperatively 0.20422 (0.18232) 0.12651 (0.18232)
T4 60 h postoperatively 0.16170 (0.0000) 0.08399 (0.0000)
Log
e
(APTR)
T0 preoperative (0) (–0.03)
T1 1 h postoperatively 0.16757 (0.15700) 0.11210 (0.11333)
T2 12 h postoperatively 0.10546 (0.06766) 0.04999 (0.04879)
T3 36 h postoperatively 0.04335 (0.04402) –0.01211 (0.06766)
T4 60 h postoperatively 0.01448 (0.01489) –0.04099 (–0.04082)
To analyze the hematologic and coagulation indices, a mixed
linear model was proposed by using Proc Mixed in the SAS
software (SAS Institute, Inc, Cary, NC). This was used to cal-
culate predicted mean values for the time points of each of the
variables. The Residual Maximum Likelihood (REML) method
was used to perform the analysis because it is considered to
have benefits when dealing with data that have missing values.14
Because time points were unequally spaced, time was first
transformed by using a log transformation to make the intervals
as equal as possible. The effect of bypass, preoperative mea-
surement, and time were considered as fixed effects. A random
intercept and coefficient for time was fitted, and the patients
were fitted as a random effect. The fixed effects were noted and
used to generate a prediction line for the hematologic variables.
The medians were included in these plots to establish the suit-
ability of the model fitted. CIs were not calculated because it
was considered that the missing data may provide misleading
results.14
Transfusion-related costs are presented as means ± SEM.
Comparison between the groups was performed by using the
unpaired t test.
Results
The randomization sequence was strictly respected.
Two patients allocated to the off-pump group crossed
over to the on-pump group right at the beginning of the
operation because hemodynamically their heart did not
tolerate the surgical maneuvers to expose the target
anastomotic site. These 2 patients were included in the
off-pump group for the intention-to-treat analysis.
The groups were similar in terms of age, body surface
area, sex ratio, diabetes mellitus, extent of coronary dis-
ease, left ventricular function, number of grafts per
patient, and graft distribution. Thirty-seven patients in
the on-pump group and 35 in the off-pump group were
in-hospital referrals with unstable angina still receiving
aspirin and low-molecular-weight heparin. The remain-
ing stable patients were elective admissions from home
in whom the aspirin had been stopped 4 days before the
operation. Distribution of preoperative and intraopera-
tive characteristics and the overall clinical outcome of
the 2 groups have been previously reported.11 Chest
tube drainage, transfusion requirement, and related
complications are reported in Table II.
Postoperative length of stay was found to be signifi-
cantly different at 8%. Further interpretation of data,
however, revealed that 75% of patients in the off-pump
group were discharged 6 days postoperatively compared
with 50% in the on-pump group. After 7 days, only 15
patients in the off-pump group remained in the hospital
compared with 29 patients in the on-pump group.
A significant difference in the number of patients re-
quiring more than 1 day in the ICU was also observed,
with the percentage of off-pump patients leaving the
ICU 1 day after the operation being 97% compared
with 75% for the on-pump group.
Because chest tube drainage was best approximated
to the normal distribution by a log10 transformation, a
comparison of the 2 groups was described by calculat-
ing a mean ratio of chest tube drainage and a 95% CI.
This was done by finding the antilog of (log10 on-pump
– log10 off-pump) and was calculated to be 1.64 (95%
CI, 1.39-1.94). The chest tube drainage was on average
1.6 times higher in the on-pump compared with that of
the off-pump group. This larger loss of blood is also
reflected in the use of transfusion units (Figs 1 and 2).
The transfusion requirements of the 2 groups were sig-
nificantly different when measured by “required” and
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Fig 1. Number of patients receiving red blood cells (RBC),
fresh frozen plasma (FFP), and platelets (PLT).
Fig 2. Number of patients receiving 1 or more units of red
blood cells.
“did not require” criteria. In the off-pump group less
than 5% of patients required FFP and platelet units,
whereas in the on-pump group it was 30% and 25%,
respectively (Table II).
The significant difference in transfusion requirement
also reflected in the related costs attributable to each
group (mean transfusion cost per patient, $184.8 ±
$35.2 and $21.47 ± $6.9 in the on-pump and off-pump
groups, respectively; P < .01).
In the on-pump group 7 patients were reoperated on
for bleeding. However, a surgical bleeding point was
identified in only 2 of these patients, a thoracic artery
bed branch in 1 patient and an atrial cannulation site in
the second patient. In the remaining 5 patients diffuse
bleeding with no obvious surgical cause was found. In
the off-pump group, 2 patients were reoperated on, 1
for a side branch of the thoracic artery and the second
for a side branch of a venous graft (Table II).
The coagulation indices were also found to differ
between the 2 groups (Table I). The predicted log10
(APTT) was lower in the off-pump group. The
observed median values were also lower in the off-
pump group, with the exception of 36 hours postopera-
tively. A similar result was observed for the log
e
(APTT
ratio). For both log
e
(INR) and log10 (PT), the predict-
ed values and observed medians were lower in the off-
pump group.
Having generated the predicted values of hemoglobin
levels, hematocrit levels, and platelet counts, these
were plotted over time, and the observed median values
were added (Fig 3, A-C). Although the 2 plots showed
a similar trend, it is noticeable that the off-pump group
would appear to have higher predicted values and
observed medians at any observation point when com-
pared with the on-pump group.
Discussion
Patients undergoing cardiac operations with CPB are
at increased risk of perioperative blood loss requiring
transfusion of blood products.15 The contact activation
with the extracorporeal circuit, shear forces, activation
of the complement system, fibrinolysis, and extrinsic
factors, such as medications, all contribute to platelet
dysfunction, which may result in increased postopera-
tive bleeding.1,16,17 The need to decrease the incidence
of postoperative bleeding and related complications
has led to the development of strategies, such as the use
of cell salvage devices to recirculate nonheparinized
blood and the routine use in some instances of drugs,
such as aprotinin or tranexamic acid.18,19
Recently, there has been a suggestion that by per-
forming coronary revascularization on the beating
heart, there may be a reduction of blood loss.7-10,20
However, no randomized study has assessed the influ-
ence of beating-heart coronary operations on both
blood loss and transfusion requirement.
This study shows a significant decrease in postoper-
ative blood loss measured as total chest tube drainage
and transfusion requirement with beating-heart opera-
tions when compared with conventional CABG with
CPB. Although the blood loss seems slightly high in
the on-pump group of our study, these losses are in
keeping with other recently published data.7,21
Furthermore, cell salvage devices and the routine use
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Table II. Chest tube drainage, transfusion, and reopening for bleeding 
Variable On-pump group (n = 100) Off-pump group (n = 100) P value
Total blood loss (mL)
Mean (95% CI) 943.19 (844-1054) 687 (624-756) <.05
Transfusion requirement
RBC units
0 48 77 <.05
≥1 52 23
FFP units
0 70 96 <.05
≥1 30 4
Platelet units
0 75 97 <.05
≥1 25 3
Total reopening (n) 8 2 .05 < P < .1
Revision for ischemia 1 0 —
Bleeding with obvious point 2 2 —
Bleeding with no obvious point 5 0 —
CI, Confidence intervals; RBC, red blood cells; FFP, fresh frozen plasma.
of tranexamic acid or aprotinin were not used in this
study. In addition, 37% of the patients in the on-pump
group and 35% in the off-pump group were unstable in-
hospital referrals managed preoperatively with aspirin
and low-molecular-weight heparin, which have been
reported to increase perioperative blood loss.22
One of the first effects of excessive bleeding is the
fall in hemoglobin and hematocrit levels. In the present
study hemoglobin and hematocrit levels decreased
more over time in the on-pump group despite this group
requiring a significantly higher transfusion of red blood
cells during the postoperative period.
The fall in the blood hemoglobin level observed at
the end of the operation in the off-pump group might be
related to intraoperative blood loss. However, the
effects of hemodilution have to be considered because
the infusion of colloid or crystalloid solutions is
required during off-pump coronary operations to main-
tain the mean systemic pressure at greater than 60 mm
Hg, particularly during the construction of the distal
anastomoses.
The explanation for the reduced postoperative blood
loss observed in the off-pump group is certainly multi-
factorial. Thrombocytopenia and its relation to postop-
erative bleeding are well documented in association
with CPB.23 Holloway and colleagues5 found that the
decrease in platelet count during CPB was in excess of
that accounted for by hemodilution for priming the
extracorporeal circuit. In this study, platelet counts in
the on-pump group show the typical time course pre-
viously reported during and after operations with
CPB.2 The greater reduction of platelet counts
throughout the study observed in the on-pump group
suggests a depletion caused by contact activation with
extracorporeal surfaces, bubble oxygenator, cardioto-
my suction, and filters.23 However, the decrease of
platelet counts in the on-pump group was rarely less
than the value (50,000-100,000/µL) normally required
for hemostasis, suggesting a degree of impaired
platelet function. Platelet dysfunction with the loss of
aggregability is largely reported as a cause of bleeding
after CPB.24,25 The absence of platelet function evalu-
ation rather than count alone is, however, a limitation
of this work.
The INR as calculated from and directly proportion-
al to the PT is a test of the extrinsic system and final
common pathway of coagulation. Clotting factor defi-
ciencies or circulating anticoagulants will therefore
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Fig 3. Predicted values (continuous line in the off-pump and dashed line in the on-pump group) and observed medi-
ans (circles, off-pump group; squares, on-pump group) over time between on- and off-pump operations for hemo-
globin level (A), hematocrit level (B), and platelet count (C).
A B
C
increase this ratio. The raised INR after CPB is report-
ed to increase both chest tube drainage and the quanti-
ty of hemostatic blood products transfused.22 The cur-
rent study also shows a higher increase over time of all
clotting screen times in the on-pump group, suggesting
an alteration of the hemostatic system.
A limitation of this study is that the analysis of
coagulation and hematologic indices was not includ-
ed in the original study design. However, the time of
observation was prospectively defined, and data were
obtained as part of the routine continuous clinical
monitoring of patients undergoing coronary opera-
tions at our institution.
As might be expected from the higher chest tube
drainage, we have also shown a significantly greater
transfusion requirement in the on-pump group. It is
worth noting that less than one quarter of the patients
in the off-pump group required transfusion compared
with over half of the patients in the on-pump group.
This finding might lead to transfusion-related com-
plications.26,27
The current era of health care has placed higher
emphasis on curtailment of costs and resources while
maintaining quality of care and patient satisfaction.
As such, the reduction of cost related to less transfu-
sion requirement observed in the off-pump group
may clearly compare with other reported strategies of
cost containment,6 while avoiding the detrimental
effect of CPB.
In conclusion, this study shows that beating-heart
coronary operations are associated with a significant
reduction in postoperative bleeding and transfusion
requirement when compared with conventional oper-
ation with CPB and cardioplegic arrest. Given that
nearly 10% of the 3.2 million annual recipients of red
blood cell transfusions in the United States are
patients undergoing CABG,28 the routine implemen-
tation of the off-pump coronary operation should have
significant implications in terms of reducing cost and
postoperative complications related to blood-product
transfusion.
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